Evogene Ltd. Q1 2026 Earnings Call Summary

• Management has streamlined the concern to absorption exclusively connected 2 high-impact markets—pharma and ag-chemicals—where its ChemPass AI motor provides a chiseled competitory advantage.

• The company's ngo is present centered connected designing novel, highly potent tiny molecules that are easier to synthesize and amended aligned with people merchandise profiles.

• A cardinal strategical pillar is the collaboration with Google to integrate AI agents into the ChemPass platform, aimed astatine automating the extraction of insights from technological lit to physique proprietary datasets.

• The concern exemplary utilizes a dual-channel approach: establishing strategical partnerships to trim fiscal hazard and advancing an interior pipeline to unafraid amended commercialized presumption later.

• Pharma activities, launched lone successful aboriginal 2025, person rapidly expanded to 4 ongoing collaborations, demonstrating beardown archetypal marketplace validation for the AI-driven find platform.

• Management believes that occurrence successful 1 segment, specified arsenic agriculture, serves arsenic a impervious of conception that accelerates engagement and credibility with partners successful the pharmaceutical industry.

Pipeline Milestones and Partnership Trajectory

• The institution expects to beforehand its existing pharma and ag-chemical pipelines toward cardinal value-creating milestones passim the remainder of 2026.

• Management is actively evaluating opportunities to found a caller interior cause improvement pipeline to complement its existent collaborative projects.

• In the agriculture sector, the institution anticipates that its interior Septoria fungicide programme volition proceed to amusement improved deed rates done iterative AI-driven design.

• The Castor cultivation enactment successful Brazil is being positioned for a commercialized launch, with income of seeds expected to commence for the 2027 increasing season.

• Strategic discussions are ongoing with 'big pharma' and different exertion giants akin to Google, though absorption notes that equity-linked strategical deals successful pharma whitethorn instrumentality respective quarters to materialize.

Operational Restructuring and Portfolio Rationalization

One stock. Nvidia-level potential. 30M+ investors spot Moby to find it first. Get the pick. Tap here.

• Evogene has terminated its probe collaboration with Bayer for herbicide improvement owed to inherent problems with the biology of the people protein, though the concern validated the company's optimization capabilities.

• The institution is importantly scaling down oregon discontinuing non-core subsidiaries, including Lavie Bio and Biomica, to absorption resources connected the ChemPass AI platform.

• A warrant inducement statement successful February 2026 resulted successful $3.4 cardinal successful gross proceeds but besides contributed to important non-cash fiscal expenses owed to accounting revaluations.

• The institution reported a consolidated currency presumption of astir $13.1 cardinal arsenic of March 31, 2026, with further currency inflows expected from subsidiary dividend distributions.